Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is T  [Clear All Filters]
2019
van den Ameele, J., Krautz, R., and Brand, A.H. (2019). TaDa! Analysing cell type-specific chromatin in vivo with Targeted DamID.Curr Opin Neurobiol56, 160-166.
Seruggia, D., Oti, M., Tripathi, P., Canver, M.C., LeBlanc, L., Di Giammartino, D.C., Bullen, M.J., Nefzger, C.M., Sun, Y.Bo Yang, Farouni, R., et al. (2019). TAF5L and TAF6L Maintain Self-Renewal of Embryonic Stem Cells via the MYC Regulatory Network.Mol Cell.
Sin-Chan, P., Mumal, I., and Huang, A. (2019). Tails of a Super Histone.Cancer Cell35, 7-9.
Hu, B. (2019). A tale of two eras: the story of autologous stem cell transplantation with and without thiotepa for primary central nervous system lymphoma.Biol Blood Marrow Transplant.
Freeman, A.F., Yazigi, N., Shah, N.N., Kleiner, D.E., Parta, M., Atkinson, P., Heller, T., Holland, S.M., Kaufman, S.S., Khan, K.M., et al. (2019). Tandem Orthotopic Living Donor Liver Transplantation Followed by Same Donor Haploidentical Hematopoietic Stem Cell Transplantation for DOCK8 Deficiency: Tandem Liver and Bone Marrow Transplant in DOCK8 Deficiency.Transplantation.
Mathot, F., Shin, A.Y., and van Wijnen, A.J. (2019). Targeted stimulation of MSCs in peripheral nerve repair.Gene.
Bort, A., Sánchez, B.G., Mateos-Gómez, P.A., Vara-Ciruelos, D., Rodríguez-Henche, N., and Díaz-Laviada, I. (2019). Targeting AMP-activated kinase impacts hepatocellular cancer stem cells induced by long-term treatment with sorafenib.Mol Oncol.
Nalivaeva, N.N., and Turner, A.J. (2019). Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.Br J Pharmacol.
Lima-Fernandes, E., Murison, A., Medina, Tda Silva, Wang, Y., Ma, A., Leung, C., Luciani, G.M., Haynes, J., Pollett, A., Zeller, C., et al. (2019). Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells.Nat Commun10, 1436.
Parizadeh, S.Mostafa, Jafarzadeh-Esfehani, R., Hassanian, S.Mahdi, Parizadeh, S.Mohammad R., Vojdani, S., Ghandehari, M., Ghazaghi, A., Khazaei, M., ShahidSales, S., Rezayi, M., et al. (2019). Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.Int J Biochem Cell Biol.
Zaghi, E., Calvi, M., Marcenaro, E., Mavilio, D., and Di Vito, C. (2019). Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy.J Leukoc Biol.
Xiao, Z., He, Y., Liu, C., Xiang, L., Yi, J., Wang, M., Shen, T., Shen, L., Xue, Y., Shi, H., et al. (2019). Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation.Oncol Rep.
Martier, R., Liefhebber, J.M., García-Osta, A., Miniarikova, J., Cuadrado-Tejedor, M., Espelosin, M., Ursua, S., Petry, H., van Deventer, S.J., Evers, M.M., et al. (2019). Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy.Mol Ther Nucleic Acids16, 26-37.
Ma, G., Shen, J., Pinz, K., Wada, M., Park, J., Kim, S., Togano, T., and Tse, W. (2019). Targeting T Cell Malignancies Using CD4CAR T-Cells and Implementing a Natural Safety Switch.Stem Cell Rev.
Chatterjee, S., and Sil, P.C. (2019). Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy.Pharmacol Res.
Short, C., Lim, H.K., Tan, J., and O'Neill, H.C. (2019). Targeting the Spleen as an Alternative Site for Hematopoiesis.Bioessayse1800234.
Fidyt, K., Pastorczak, A., Goral, A., Szczygiel, K., Fendler, W., Muchowicz, A., Bartlomiejczyk, M.Adam, Madzio, J., Cyran, J., Graczyk-Jarzynka, A., et al. (2019). Targeting the thioredoxin system as a novel strategy against B cell acute lymphoblastic leukemia.Mol Oncol.
Potter, A., Beck, B., and Ngorsuraches, S. (2019). Tbo-filgrastim versus filgrastim for stem cell mobilization and engraftment in autologous hematopoietic stem cell transplant patients: A retrospective review.J Oncol Pharm Pract1078155219833444.
Zhang, B., Wu, J., Cai, Y., Luo, M., Wang, B., and Gu, Y. (2019). TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer.Acta Biochim Biophys Sin (Shanghai).
Stefanovic, L., and Stefanovic, B. (2019). Technology for Discovery of Antifibrotic Drugs: Phenotypic Screening for LARP6 Inhibitors Using Inverted Yeast Three Hybrid System.Assay Drug Dev Technol.
Zhang, X., Liu, Z., Liu, X., Wang, S., Zhang, Y., He, X., Sun, S., Ma, S., Shyh-Chang, N., Liu, F., et al. (2019). Telomere-dependent and telomere-independent roles of RAP1 in regulating human stem cell homeostasis.Protein Cell.
Shrestha, S., and Kishen, A. (2019). Temporal-controlled bioactive molecules releasing Core-shell Nano-system for tissue engineering strategies in endodontics.Nanomedicine.
Rinoldi, C., Costantini, M., Kijeńska-Gawrońska, E., Testa, S., Fornetti, E., Heljak, M., Ćwiklińska, M., Buda, R., Baldi, J., Cannata, S., et al. (2019). Tendon Tissue Engineering: Effects of Mechanical and Biochemical Stimulation on Stem Cell Alignment on Cell-Laden Hydrogel Yarns.Adv Healthc Matere1801218.
Xu, T., Xu, M., Bai, J., Lin, J., Yu, B., Liu, Y., Guo, X., Shen, J., Sun, H., Hao, Y., et al. (2019). Tenocyte-derived exosomes induce the tenogenic differentiation of mesenchymal stem cells through TGF-β.Cytotechnology.
Stanco, D., Caprara, C., Ciardelli, G., Mariotta, L., Gola, M., Minonzio, G., and Soldati, G. (2019). Tenogenic differentiation protocol in xenogenic-free media enhances tendon-related marker expression in ASCs.Plos One14, e0212192.

Pages